Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abionyx Pharma (ABNX.FP)

Abionyx Pharma (ABNX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abionyx Pharma 33-43 Avenue Georges Pompidou-Bat D2 Balma 31130 FRA

P: +33 562249706

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.

Key Statistics

Overview:

Market Capitalization, $K 115,716
Shares Outstanding, K 35,293
% of Institutional Shareholders 0.23%

Financials:

Annual Sales, $ 4,551 K
Annual Net Income, $ -4,381 K

Growth:

1-Year Return 153.07%
3-Year Return 59.95%
5-Year Return 231.80%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.13
Dividend Payout Ratio 0.00%

ABNX.FP Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -61.53%
Return-on-Assets % -32.25%
Profit Margin % -96.26%
Debt/Equity 0.25
Price/Sales 29.03
Price/Cash Flow N/A
Price/Book 21.04
Book Value/Share 0.16
Interest Coverage -117.41
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar